Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Trial details
- Registry ID
- NCT07484217
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using SolriamfetolNCT07484217 | AXSM | Phase 3 | Recruiting | 2028-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |